loadpatents
Patent applications and USPTO patent grants for Glue; Paul W..The latest application filed is for "combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides".
Patent | Date |
---|---|
Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides App 20060052373 - Glue; Paul W. ;   et al. | 2006-03-09 |
HCV combination therapy Grant 6,849,254 - Brass , et al. February 1, 2 | 2005-02-01 |
Ribavirin-pegylated interferon alfa induction HCV combination therapy Grant 6,824,768 - Stalgis , et al. November 30, 2 | 2004-11-30 |
HIV Therapy App 20020182179 - Laughlin, Mark A ;   et al. | 2002-12-05 |
Ribavirin-pegylated Interferon Alfa Induction Hcv Combination Therapy App 20020119122 - STALGIS, CARLOS O. ;   et al. | 2002-08-29 |
Method of reducing craving in mammals App 20010025038 - Coffin, Vicki L. ;   et al. | 2001-09-27 |
Method of reducing nicotine and tobacco craving in mammals Grant 6,262,049 - Coffin , et al. July 17, 2 | 2001-07-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.